🍽️ high-fat sucrose

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

Data Contradictions β€” Limits of Certainity

Impacted of high-fat sucrose On Probiotics

Rank Probiotic Impact

Bacteria Impacted by high-fat sucrose

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Clostridia class Decreases 📓 Source Study
Bacilli class Increases 👪 Source Study
Bacteroidia class Increases 👪 Source Study
Erysipelotrichia class Increases 👪 Source Study
Aerococcaceae family Increases 👶 Source Study
Bacteroidaceae family Increases 👶 Source Study
Balneicellaceae family Increases 👶 Source Study
Barnesiellaceae family Increases 👶 Source Study
Carnobacteriaceae family Increases 👶 Source Study
Coprobacillaceae family Increases 👶 Source Study
Dysgonomonadaceae family Increases 👶 Source Study
Enterococcaceae family Increases 👶 Source Study
Erysipelotrichaceae family Increases 👶 Source Study
Lactobacillaceae family Increases 👶 Source Study
Leuconostocaceae family Increases 👶 Source Study
Muribaculaceae family Increases 👶 Source Study
Odoribacteraceae family Increases 👶 Source Study
Paludibacteraceae family Increases 👶 Source Study
Porphyromonadaceae family Increases 👶 Source Study
Prevotellaceae family Increases 👶 Source Study
Rikenellaceae family Increases 👶 Source Study
Salinivirgaceae family Increases 👶 Source Study
Streptococcaceae family Increases 👶 Source Study
Tannerellaceae family Increases 👶 Source Study
Tenuifilaceae family Increases 👶 Source Study
Turicibacteraceae family Increases 👶 Source Study
Aerosphaera genus Increases ⚗️ Source Study
Proteiniphilum genus Increases ⚗️ Source Study
Clostridia incertae sedis no rank Decreases 👶 Source Study
environmental samples no rank Decreases 👶 Source Study
unclassified Clostridia no rank Decreases 👶 Source Study
unclassified Megasphaera no rank Decreases ⚗️ Source Study
Bacteroidales incertae sedis no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
Lactobacillales incertae sedis no rank Increases 👶 Source Study
unclassified Bacteroidales no rank Increases 👶 Source Study
Caldicellulosiruptorales order Decreases 👶 Source Study
Eubacteriales order Decreases 👶 Source Study
Halanaerobiales order Decreases 👶 Source Study
Koleobacterales order Decreases 👶 Source Study
Moorellales order Decreases 👶 Source Study
Natranaerobiales order Decreases 👶 Source Study
Thermoanaerobacterales order Decreases 👶 Source Study
Thermosediminibacterales order Decreases 👶 Source Study
Bacteroidales order Increases 📓 Source Study
Erysipelotrichales order Increases 📓 Source Study
Lactobacillales order Increases 📓 Source Study
Bacillota phylum Decreases 👪 Source Study
Aerosphaera taetra species Increases ⚗️ Source Study

Impact of high-fat sucrose on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.4 1.2 -2
ADHD 0.4 1.3 -2.25
Allergic Rhinitis (Hay Fever) 0.2 0.6 -2
Allergies 0.7 1.2 -0.71
Allergy to milk products 1.2 0.3 3
Alopecia (Hair Loss) 0.3 0.2 0.5
Alzheimer's disease 0.9 2 -1.22
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.9 -0.9
Ankylosing spondylitis 0.2 1.2 -5
Anorexia Nervosa 0.2 2 -9
Asthma 0.2 0.6 -2
Atherosclerosis 0.3 0.3
Atrial fibrillation 0.2 0.2
Autism 1.2 1.1 0.09
Barrett esophagus cancer 0.4 0.4
Bipolar Disorder 0.4 0.6 -0.5
Brain Trauma 1.6 1.6
Celiac Disease 0.5 0.3 0.67
Chronic Fatigue Syndrome 0.2 1.7 -7.5
Chronic Kidney Disease 0.3 -0.3
Chronic Obstructive Pulmonary Disease (COPD) 0.2 0.2
Chronic Urticaria (Hives) 0.3 0.6 -1
Coagulation / Micro clot triggering bacteria 1.3 1.3
Colorectal Cancer 0.9 0.9 0
Constipation 0.2 0.4 -1
COVID-19 1.1 2.3 -1.09
Crohn's Disease 0.3 2 -5.67
deep vein thrombosis 0.8 0.8
Depression 2.3 2.9 -0.26
Dermatomyositis 0.6 -0.6
Eczema 0.2 1.1 -4.5
Endometriosis 0.4 0.2 1
Eosinophilic Esophagitis 1.2 -1.2
Epilepsy 0.4 0.4 0
Fibromyalgia 0.2 0.2
Functional constipation / chronic idiopathic constipation 0.4 1.1 -1.75
gallstone disease (gsd) 0.2 -0.2
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.3 0.3
Generalized anxiety disorder 0.6 0.6
giant cell arteritis 0.6 -0.6
Gout 2.4 -2.4
Graves' disease 0.2 3.3 -15.5
Halitosis 0.2 0.2
Hashimoto's thyroiditis 0.2 0.2
Hidradenitis Suppurativa 0.3 -0.3
hypercholesterolemia (High Cholesterol) 0.4 0.4
hyperglycemia 0.2 -0.2
Hyperlipidemia (High Blood Fats) 1 1
hypersomnia 0.2 0.2
hypertension (High Blood Pressure 0.3 0.2 0.5
Inflammatory Bowel Disease 0.3 0.4 -0.33
Insomnia 0.2 0.4 -1
Intelligence 0.4 0.4
Intracranial aneurysms 0.2 0.2
Irritable Bowel Syndrome 0.7 0.8 -0.14
Juvenile idiopathic arthritis 0.3 -0.3
Long COVID 2.7 3.5 -0.3
Lung Cancer 0.4 0.7 -0.75
Metabolic Syndrome 1.1 1.4 -0.27
Mood Disorders 3.2 3.4 -0.06
multiple chemical sensitivity [MCS] 0.2 0.2
Multiple Sclerosis 1 0.3 2.33
Neuropathy (all types) 0.7 0.3 1.33
neuropsychiatric disorders (PANDAS, PANS) 0.4 0.6 -0.5
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.2 0.6 1
Obesity 1.3 1.3 0
Osteoarthritis 0.3 -0.3
Osteoporosis 0.7 0.8 -0.14
Parkinson's Disease 0.6 1.5 -1.5
Polycystic ovary syndrome 0.2 0.4 -1
Premenstrual dysphoric disorder 0.3 0.3
primary biliary cholangitis 0.2 -0.2
Psoriasis 0.6 0.3 1
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.6 1.8 -0.13
Rosacea 0.6 -0.6
Schizophrenia 1.3 1.4 -0.08
sensorineural hearing loss 0.2 -0.2
Sjögren syndrome 0.3 0.3
Sleep Apnea 0.4 0.4
Small Intestinal Bacterial Overgrowth (SIBO) 0.3 -0.3
Stress / posttraumatic stress disorder 0.4 -0.4
Systemic Lupus Erythematosus 0.9 2.6 -1.89
Tic Disorder 0.2 0.2
Tourette syndrome 0.2 0.2
Type 1 Diabetes 0.3 0.5 -0.67
Type 2 Diabetes 0.9 1.3 -0.44
Ulcerative colitis 1.5 2.7 -0.8

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)